Navigation Links
Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
Date:6/1/2008

please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strategic goals, drug development plans, results of clinical trials and the potential safety and efficacy of its products in development. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre-clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2008 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are t
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
2. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
3. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
4. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
5. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
6. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
7. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
8. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
11. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... 17 Kensey Nash Corporation (Nasdaq: KNSY ) is scheduled to present at the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor ... ... , ... ... ...
(Date:3/17/2010)... -- Micromet, Inc. (Nasdaq: MITI ) announced today the closing of its previously ... to purchase an additional 1.5 million shares of common stock. As a result, Micromet ... offering price of $7.00 per share. , ... ... , ...
(Date:3/17/2010)... March 17 OrbusNeich today announced that 12 month follow up data from real world patients demonstrated long term clinical efficacy of the ... ... ... ... Margo Klomp ...
Breaking Medicine Technology:Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum 2Micromet Closes $80.5 Million Public Offering of Common Stock 2Micromet Closes $80.5 Million Public Offering of Common Stock 3Micromet Closes $80.5 Million Public Offering of Common Stock 4Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 3Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 4Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 1Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 2Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 3Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 1Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 2Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 3Capital Gold Group Donates to American Red Cross Disaster Relief for Victims of Southern California Wildfires 57552 1Capital Gold Group Donates to American Red Cross Disaster Relief for Victims of Southern California Wildfires 57552 2
(Date:3/18/2010)... IDMI Systems Inc., a developer of automation software for the insurance industry based in Warner Robins, Ga. , has contracted with Companion Global Healthcare ® ... ... , , ... ... ...
(Date:3/18/2010)... babies born with cleft palates have made a promising ... early next year. Clefts are the most common birth ... affected; currently in severe cases radical surgery is required ... can occur as the child grows into an adult. ... the Science and Technology Facilities Council,s ISIS neutron source ...
(Date:3/18/2010)... and Management. , ... ... NHS Lincolnshire, a Primary Care Trust responsible for improving ... completed the deployment of Aerohive Networks’ award-winning ... its key healthcare facilities. The Aerohive WLAN is ...
(Date:3/18/2010)... for Metabolic and Bariatric Surgery (ASMBS) Bariatric Surgery Center of ... unique and specially designed bariatric medical devices and at the ... , ... (PRWEB) March 18, 2010 -- ... medical and surgical devices, today announced a collaboration with Surgical ...
(Date:3/18/2010)... in study participants, , , THURSDAY, March 18 (HealthDay News) ... seizures in people who had not responded to other ... stimulation came from a pacemaker-like device that was implanted ... leads from the device ran under the skin to ... to the thalamus, a "relay station" deep within the ...
Breaking Medicine News(10 mins):Health News:Georgia Firm Adds Medical Travel to Cut Costs, Provide Options for Workers 2Health News:Georgia Firm Adds Medical Travel to Cut Costs, Provide Options for Workers 3Health News:Breakthrough for babies born with severe cleft palates after experiments at ISIS 2Health News:Breakthrough for babies born with severe cleft palates after experiments at ISIS 3Health News:NHS Lincolnshire Applies Intuitive ‘Cooperative Control' Wireless LAN 2Health News:NHS Lincolnshire Applies Intuitive ‘Cooperative Control' Wireless LAN 3Health News:Eisner USA, LLC Collaborates with Surgical Review Corp to Provide Innovative Bariatric Devices to Bariatric Surgery Center of Excellence (BSCOE) Participants 2Health News:Eisner USA, LLC Collaborates with Surgical Review Corp to Provide Innovative Bariatric Devices to Bariatric Surgery Center of Excellence (BSCOE) Participants 3Health News:Implant Shows Promise for Hard-to-Treat Epilepsy 2
... Pediatric Patient Education at ... ... Del., March 11 ,GetWellNetwork, Inc., a leading provider of Interactive ... pediatric health,information, today announced a partnership to co-develop a comprehensive,suite ...
... CUPERTINO, Calif., March 11 DURECT,Corporation (Nasdaq: ... and,Chief Executive Officer, will be presenting at the ... 17, 2008 at 4:00 p.m. EST. The,conference is ... (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ), A live ...
... China, March 11 /Xinhua-PRNewswire-FirstCall/ -- Viscorp Inc.,(OTC Bulletin ... modernized,traditional Chinese medicine ("TCM") based in Chengdu, China, ... Tianyin Pharmaceutical, Co., Inc.,The corporate name change is ... 2008, the Company will trade under a,new symbol ...
... offer a new way to detect and treat autism during ... months of life, when the brain is ... agree that,the earlier autism is diagnosed and therapy begun, the ... even when parents have an intuition,that "something is amiss" with ...
... Three Fruit Flavors, This Certified Organic, Low Fat, Rich ... Fulfilling Snack or Meal Replacement, FULLERTON, Calif., March ... leading U.S. provider of soy food,products, today launched Probiotic ... fat, kosher and contains eight (8),grams of soy protein ...
... Calif., March 11 HOYA ConBio(TM), a global,leader ... dentists who,purchase DioDent(TM) Micro 980 soft tissue lasers ... Advanced Laser,Training, a company dedicated to dental laser ... ConBio,s corporate commitment to comprehensive,laser dentistry education., ...
Other Medicine News:Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 2Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 3Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 4Health News:Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker 'OTC BB: TYNP' 2Health News:Autism Awareness Month - New Hope for Detecting/Reversing Autism in Infants 2Health News:Wildwood Organics Introduces Probiotic Soymilk(TM) 2Health News:HOYA ConBio Partners With Advanced Laser Training to Offer Complementary Laser Certification Course in Dentistry 2
... A & B Test simplifies rapid ... on the market just got easier ... and influenza B using one simple ... can focus on the results and ...
... The Clearview hCG Combo with ... rapid detection of human chorionic ... serum specimens. This test kit ... qualitative result and is intended ...
... loupes available at manufacturer-direct prices. ... optical design, combining superior quality withunmatched ... maximum comfort, SheerVision loupes are the ... Make both a professional and a ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. Make both a ...
Medicine Products: